Lymphocyte subpopulations bearing different surface markers in non-Hodgkin lymphoma. 1978

J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa

Lymphoid cells isolated from peripheral blood and lymph nodes were examined by using the rosette test with sheep erythrocytes (E), the immunofluorescent staining of the surface immunoglobulins (SmIg), the rosette test with mouse C 57 BL erythrocytes (Em and a combined test (SmIg + E). These studies were performed in 143 patients with various subtypes of non-Hodgkin lymphoma and in 110 controls. In the control group the following percentage of cell types was obtained: 1) blood (n = 110): T-68 +/- 12, B- 20 +/- 3, O- 11 +/- 7, BT- 1 +/- 1.4, Em+ cells--9 +/- 7, C3+ cells--21 +/- 3, 2) lymph nodes (n = 23): T- 66 +/- 10, B- 17 +/- 10, O- 15.7 +/- 9, BT- 0.8 +/- 1.7. In non-Hodgkin lymphoma lymph nodes a statistically significant increase of null and B cells- was noted in comparison to the controls (p less than 0.001). Similar changes were observed in the blood of non-Hodgkin lymphoma patients in which the leukocyte count exceeded 10(3)/microliter, whereas in the cases with low leukocythosis the B-T values were within the nomal range. It is concluded that the marker studied does allow to differentiate in most cases between the non-Hodgkin lymphoma and other disorders of the lymphoid system. They also give additional information about the more exact nature of the lymphoid malignancies.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
January 1987, Acta medica Hungarica,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
January 1978, The Journal of laboratory and clinical medicine,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
January 1978, The Journal of laboratory and clinical medicine,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
January 1983, Diagnostic immunology,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
December 1979, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
December 1976, Lancet (London, England),
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
July 2014, Pathology oncology research : POR,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
May 1981, Orvosi hetilap,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
December 1976, British journal of haematology,
J Hołowiecki, and J Japa, and E Szeruda-Rudzka, and B Stella-Hołowiecka, and M Krawczyk, and K Jarczok, and B Rosa
January 2013, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!